BMY News 50.50 04/26/2014 00:25:58 Bristol-Myers Squibb Company

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bristol-Myers Squibb Company (BMY) 50.50 $BMY

Hepatitis C Space Heats Up
Brian Orelli, The Motley Fool - Motley Fool - Fri Apr 25, 5:30PM CDT
What looked like a two-horse hepatitis C race between Gilead Sciences and AbbVie has gotten more interesting, with Merck and Bristol-Myers Squibb presenting data on their hepatitis C drugs at a scientific meeting earlier this month. ...

3 Questions About a Big Pharma Megamerger
Seth Robey, The Motley Fool - Motley Fool - Fri Apr 25, 1:30PM CDT
It's been hard to miss the action in Big Pharma this week, as some of the most established drug makers engaged in a series of acquisition, merger, and asset swap rumors. A buyout of English company AstraZeneca by American powerhouse Pfizer was...

Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb
PR Newswire - Fri Apr 25, 1:09PM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Nokia OYJ (NYSE: NOK), Boston Scientific Corp. (NYSE: BSX), Merck & Co. Inc. (NYSE: MRK) and Bristol-Myers Squibb Co. (NYSE: BMY). Full earnings notes on NOK, BSX, MRK and BMY can be downloaded upon signing up at:

Midday Glance: Pharmaceuticals companies
AP - Fri Apr 25, 12:23PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:

Early Glance: Pharmaceuticals companies
AP - Fri Apr 25, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

What You Should Know About Gilead's Sovaldi And Johnson & Johnson's Olysio
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 24, 5:30PM CDT
Over the past five years, few drugs have been as highly anticipated as Gilead's Sovaldi, a new-generation oral treatment for hepatitis C infection. Sovaldi won FDA approval in December, and despite only being available for a few weeks, Sovaldi...

Final Glance: Pharmaceuticals companies
AP - Thu Apr 24, 5:04PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

Alexion Posts Strong Earnings in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 4:00PM CDT
Alexion (ALXN) handsomely beat the Zacks Consensus Estimate in the first quarter.

Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List
Business Wire - Thu Apr 24, 12:01PM CDT
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has been ranked No. 1 on Corporate Responsibility magazine's 2014 list of the 100 Best Corporate Citizens, a leading benchmark for socially responsible investors and other stakeholders.

The Medicines Co.'s Q1 Earnings Surpass Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 10:40AM CDT
The Medicines Co. (MDCO) also announced an acquisition agreement which reflects its efforts to diversify its portfolio and reduce its dependence on Angiomax.

Is This Struggling Drugmaker Worth $100 Billion?
Dan Carroll, The Motley Fool - Motley Fool - Thu Apr 24, 8:30AM CDT
The pharmaceutical world got a shock this week from   reports that  Pfizer    had engaged in informal talks with Big Pharma rival  AstraZeneca    about a possible $100 billion acquisition. AstraZeneca reportedly  expressed no interest in the...

The Zacks Analyst Blog Highlights andora Media, Apple, Sirius XM, Bristol-Myers Squibb and Five Prime Therapeutics
PR Newswire - Thu Apr 24, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Pandora Media, Inc. (NYSE -Free Report), Apple (Nasdaq:AAPL-Free Report), Sirius XM (Nasdaq:SIRI-Free Report), Bristol-Myers Squibb Company (NYSE:BMY-Free Report) and Five Prime Therapeutics, Inc. (Nasdaq:FPRX-Free Report).

AstraZeneca's Q1 Profit Falls 11% Despite Strong Diabetes Drug Growth
Sean Williams, The Motley Fool - Motley Fool - Thu Apr 24, 7:36AM CDT
Just days after rumors swirled about a possible takeover offer, global pharmaceutical giant AstraZeneca reported its first-quarter results very early this morning, delivering modest top-line growth but seeing its profits shrink notably. For...

Allied Minds Names Peter Dolan and Jeff Rohr to Board of Directors
Business Wire - Thu Apr 24, 7:03AM CDT
Allied Minds, a dedicated technology commercialization firm that develops businesses and products based on innovative technologies developed at US universities and federal research institutions, today announced the appointment of Peter Dolan and Jeff Rohr as new members of its Board of Directors, effectively immediately.

Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie
PR Newswire - Thu Apr 24, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Bristol-Myers Squibb Company (NYSE: BMY) and AbbVie Inc. (NYSE: ABBV). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1516-100free.

Will These 3 Dividend Stocks Impress Investors This Earnings Season?
Dan Carroll, The Motley Fool - Motley Fool - Wed Apr 23, 5:30PM CDT
Earnings season already has produced its fair share of surprises, but big pharma's hardly even broken out of the gate so far. However, a trio of major drugmakers are set to release their quarterly results in the next two weeks, and all eyes in the...

Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 4:30PM CDT
Bristol-Myers Squibb Company (BMY) expanded its existing manufacturing agreement with Samsung BioLogics.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alliance for Women in Media Champions Change in 2026

Updated Category News Views 87

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 141

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 104

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 120

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Ozelle Unveils AI-Powered Hematology Tool at MEDICA 2026

Updated Category News Views 124

Pioneering a New Era in Hematology In the fast-paced world of blood analysis, standing still means being left in the dust. Ozelle, with its AI-powered innovative tool, is making waves at MEDICA 2026 in Düsseldorf. Meet O-Cyte 1, an automated hematology analyzer that's merging high-resolution cell imaging with routine CBC (Complete Blood Count) testing. Sounds like...

Continue Reading
Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 61

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 23

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 128

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 199

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading

Top 5 Most Recently Viewed Articles

Formula Wellness Scores Top 50 Position from Allergan

Updated Category News Views 15

Pushing Boundaries in Aesthetic and Wellness Here's something you don't see every day: Formula Wellness just landed Top 50 status for 2026 from Allergan Aesthetics, the same folks who brought Botox to the world. It’s no small feat, and if you've been keeping an eye on sectors blending wellness with aesthetics, this might be the story to watch. Formula Wellness isn't...

Continue Reading
iTeos Therapeutics Showcases Inupadenant Trial Insights at ESMO

Updated Category News Views 98

Introduction to iTeos Therapeutics and ESMO Congress iTeos Therapeutics, Inc. (NASDAQ: ITOS), based in Watertown, Mass. and Gosselies, Belgium, is making strides in the field of biopharmaceuticals. Their mission focuses on pioneering a new wave of immuno-oncology therapies aimed at fighting cancer. The excitement around their innovative approaches is palpable, especially...

Continue Reading
Plastic vs. Metal Parts: The Manufacturing Showdown

Updated Category News Views 65

Understanding the Material Dilemma In manufacturing, a pivotal choice emerges early on: plastic or metal? It's a game-changer in product development, according to Ryan Eggleston from UTP Solutions. The stakes are high because picking the right material can define the success—or failure—of a product design. The Rise of Plastics Plastics have carved out a strong niche...

Continue Reading
Fast Debt Recovery Specialist Sets New Standards in Compliance

Updated Category News Views 105

Fast Debt Recovery Specialist Earns Newly Required License Fast Debt Recovery Specialist has marked a major milestone, becoming one of the first firms in Singapore to secure the government’s newly required debt collection license. It’s a clear signal: the agency intends to operate squarely within the law while holding fast to ethical, transparent recovery practices....

Continue Reading
Rivian's 2024 Performance: Impressive Production and Delivery Stats

Updated Category News Views 327

Rivian Announces Strong Production and Delivery Figures for 2024 Rivian Automotive, Inc. (NASDAQ: RIVN), a leading player in the electric vehicle market, has revealed its impressive production and delivery totals for 2024. The company successfully produced a remarkable 12,727 vehicles in the fourth quarter alone, rounding off a total annual production of 49,476 vehicles....

Continue Reading